Patent Assignment
Reel/Frame 062672/0612
Assignment of Assignor's Interest
Recorded: 2023-02-13
Pages: 4
Assignors
PORADOSU, ENRIQUE
Executed: 2014-02-03
OLIVIERO, III, JAMES F.
Executed: 2014-02-03
BENTSUR, RON
Executed: 2014-02-03
Assignee
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE, 20TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Property
(1)
Use of Ferric Citrate in the Treatment of Chronic Kidney Disease Patients
Application:
18/147,240 →
Publication:
US 2024/0041816
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Thirteenth Amended and Restated Intellectual Property Security Agreement
Mar 29, 2023
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063189/0065 →
Fifteenth Amended and Restated Intellectual Property Security Agreement
Jan 4, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066205/0143 →
Termination and Release of Security Interest in Patents
Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Security Interest
Jan 29, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 066377/0654 →
Termination and Release of Security Interest in Patents
Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →